WuXi Vaccines Launches Its First Vaccines CDMO Site in China

555

1 comment

Staff at TrialSite | Quality Journalism

Sep. 29, 2023, 11:00 p.m.

Contract development and manufacturing organization (CDMO) WuXi Vaccines, a subsidiary of WuXi Biologics, announced the launch its first standalone vaccines CDMO site in Suzhou, China. The facility was acquired from Harbour BioMed late last year.

Located about 110 km west of Shanghai, Suzhou, has about 11 million people and is known for its canals, bridges and classical gardens.

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month
which is less than a Starbucks coffee!

Peter Gabriel, MD

"Publishing on TrialSite helped me secure a $20m research grant for my work."

Jona Savinda

"TrialSiteNews is my daily read for what is happening in the industry."